IP Litigation
Intellectual property lawsuits are not only on the rise, but are now some of the most costly litigations that companies face. Awards and settlements are potentially huge, and injunctions have the potential to fundamentally change competitive landscapes.
Our rigorous economic and financial analyses have assisted scores of clients in resolving disputes involving patents, copyrights, trademarks, trade secrets, and other intangible assets. Our work is complemented by our knowledge of many industries, and our use of
cutting-edge analytical tools and techniques such as machine
learning.
Types of Expertise
We have an extensive network of affiliated academic experts, industry executives, and internal consultants with expertise in a variety of topics that frequently arise in IP cases:
- Bonding
- Commercial success
- Damages
- Domestic industry
- Financial modeling
- FRAND compliance
- Irreparable harm
- Licensing
- Research and survey methods
- Technology transfer
- Unjust enrichment
- Valuation
Case Mix
Our consultants have experience in litigation and arbitration involving all types of IP cases:
- Patent infringement
- Copyright infringement
- Trademark infringement
- Misappropriation of trade secrets
- Unfair competition
- Breach of contract
- Non-competes
Venues
We have presented the results of our work in many venues, including:
- Federal district court
- International Trade Commission (ITC)
- State courts
- International and domestic arbitration boards
Industries
Our litigation work, academic studies, and industry experience cover a wide range of technologies, products, and services, including:
- Agriculture
- Automotive
- Biotechnology
- Chemicals
- Construction
- Consumer products
- Electronics
- Entertainment
- Health care
- Industrial products
- Internet
- Machinery
- Pharmaceutical
- Professional and business services
- Real estate
- Telecommunications
- Textiles and apparel
- Transportation
- Travel
- Utilities
- Wholesale trade
-
Forum
Assessing Commercial Success at the US Patent Trial and Appeal Board
-
Video
John Jarosz - Delivering Expert Testimony on Intellectual Property Valuation
-
Case Outcome
Otsuka Pharmaceuticals Abilify Litigations
-
Forum
“Similar” but Not the Same: Charting the Course of Biosimilar IP Litigation in the US